Five things for pharma marketers to know: Thursday, December 8, 2016

1. A California lawmaker reintroduced a bill that would require drugmakers to notify the state health agencies and commercial payers before they raise the prices of their therapies. A ballot measure that would have required state agencies to pay the same amount for drugs as the Veterans Affairs failed to pass in November. (California Healthline)

2. France, Poland, Spain, and Sweden are lobbying to host the European Medicines Agency in light of the United Kingdom's decision to exit the European Union. The EMA is currently based in London. (Reuters)

3. Pharmaceutical stocks dropped after President-elect Trump told Time magazine that he's “going to bring down drug prices.” The stocks of Pfizer, Johnson & Johnson, and Merck fell, as did Celgene and Biogen stocks. (WSJ)

4. The Centers for Medicare and Medicaid Services this week released a price history of 5,000 drugs. It found that prices of certain generic drugs rose by triple-digit percentages during a five-year period. (Modern Healthcare)

5. Horizon Pharma's Actimmune failed in a late-stage trial to treat Friedreich's ataxia, a rare neuromuscular disorder. The drug did not show a benefit when compared to patients taking a placebo. (Reuters)